(Q33179393)

23 July 2017

Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status (English)

1 reference

23 July 2017

1 reference

1 reference

6

P Wesseling

1 reference

23 July 2017

H J Bernsen

1

1 reference

23 July 2017

P F Rijken

2

1 reference

23 July 2017

J P Peters

3

1 reference

23 July 2017

J H Bakker

4

1 reference

23 July 2017

R H Boerman

5

1 reference

23 July 2017

A J van der Kogel

7

1 reference

23 July 2017

1 September 1999

1 reference

Journal of Neuro-Oncology

23 July 2017

1 reference

23 July 2017

44

1 reference

23 July 2017

2

1 reference

23 July 2017

129-136

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006363215260

23 July 2017

0 references

cites work

Suramin inhibits glioma cell proliferation in vitro and in the brain.

1 reference

12 December 2020

Suramin: an anticancer drug with unique biological effects

1 reference

12 December 2020

Suramin analogues with a 2-phenylbenzimidazole moiety as partial structure; potential anti HIV- and angiostatic drugs, 2: Sulfanilic acid-, benzenedisulfonic acid-, and naphthalenetrisulfonic acid analogues

1 reference

12 December 2020

Suramin is a Potent Inhibitor of Vascular Endothelial Growth Factor. A Contribution to the Molecular Basis of its Antiangiogenic Action

1 reference

12 December 2020

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

1 reference

12 December 2020

Suramin inhibits C6 glioma-induced angiogenesis in vitro.

1 reference

12 December 2020

The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.

1 reference

12 December 2020

A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions

1 reference

12 December 2020

Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.

1 reference

12 December 2020

Angiogenesis in malignant gliomas

1 reference

12 December 2020

Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts

1 reference

12 December 2020

Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity

1 reference

12 December 2020

Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model

1 reference

12 December 2020

Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.

1 reference

12 December 2020

Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.

1 reference

12 December 2020

Nature of the interaction of growth factors with suramin

1 reference

12 December 2020

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator

1 reference

12 December 2020

Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation

1 reference

12 December 2020

Angiogenesis inhibition: a review

1 reference

12 December 2020

Inhibition of angiogenesis by suramin

1 reference

12 December 2020

Tumor oxygenation: a matter of supply and demand.

1 reference

12 December 2020

Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice

1 reference

12 December 2020

Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

12 December 2020

Determinants of tumor blood flow: a review

1 reference

12 December 2020

Antiproliferative and angiostatic activity of suramin analogues

1 reference

12 December 2020

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

12 December 2020

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

1 reference

12 December 2020

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1 reference

12 December 2020

Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.

1 reference

12 December 2020

Inhibition of Breast Cancer Growth by Suramin

1 reference

12 December 2020

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

1 reference

12 December 2020

Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients

1 reference

12 December 2020

Antiangiogenic and antiproliferative activity of suramin analogues

1 reference

12 December 2020

The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma

1 reference

12 December 2020

Tumor angiogenesis: a quantitative method for histologic grading.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006363215260

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference